These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8030847)

  • 1. Impaired antibody response to influenza vaccine in institutionalized elderly.
    Provinciali M; Di Stefano G; Muzzioli M; Scarpazza P; Colombo D; Migliorino M; Bellani M; Colombo M; Della Croce F; Gandolfi MC
    Ann N Y Acad Sci; 1994 Jun; 717():307-14. PubMed ID: 8030847
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody response to 1995-1996 influenza vaccine in institutionalized and non-institutionalized elderly women.
    Iorio AM; Alatri A; Camilloni B; Neri M; Baglio G; Donatelli I
    Gerontology; 1999; 45(1):31-8. PubMed ID: 9852378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients.
    Van Hoecke C; Prikazsky V; Utö I; Menschikowski C
    Gerontology; 1996; 42(4):190-8. PubMed ID: 8832266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.
    Nunzi E; Iorio AM; Camilloni B
    Hum Vaccin Immunother; 2017 Nov; 13(11):2659-2668. PubMed ID: 28922621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination in elderly people.
    Remarque EJ
    Exp Gerontol; 1999 Jun; 34(3):445-52. PubMed ID: 10433399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response to influenza vaccination in the elderly: a quantitative review.
    Goodwin K; Viboud C; Simonsen L
    Vaccine; 2006 Feb; 24(8):1159-69. PubMed ID: 16213065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects.
    Fülöp T; Wagner JR; Khalil A; Weber J; Trottier L; Payette H
    J Gerontol A Biol Sci Med Sci; 1999 Feb; 54(2):M59-64. PubMed ID: 10051856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine.
    Powers DC; Belshe RB
    J Infect Dis; 1993 Mar; 167(3):584-92. PubMed ID: 8440930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Better influenza vaccines for older people: what will it take?
    McElhaney JE; Dutz JP
    J Infect Dis; 2008 Sep; 198(5):632-4. PubMed ID: 18652548
    [No Abstract]   [Full Text] [Related]  

  • 10. Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging.
    de Bourcy CF; Angel CJ; Vollmers C; Dekker CL; Davis MM; Quake SR
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1105-1110. PubMed ID: 28096374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly.
    Deng Y; Jing Y; Campbell AE; Gravenstein S
    J Immunol; 2004 Mar; 172(6):3437-46. PubMed ID: 15004143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal surveillance of the humoral immunity against influenza vaccine in the elderly over 9 consecutive years.
    Odelin MF; Momplot C; Bourlet T; Gonthier R; Aymard M; Pozzetto B
    Gerontology; 2003; 49(4):233-9. PubMed ID: 12792158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosenescence: role and measurement in influenza vaccine response among the elderly.
    Targonski PV; Jacobson RM; Poland GA
    Vaccine; 2007 Apr; 25(16):3066-9. PubMed ID: 17275144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to influenza vaccine in people with non-protective HI antibody titers.
    Baldo V; Baldovin T; Floreani A; Minuzzo M; Trivello R
    Eur J Epidemiol; 2006; 21(11):843-5. PubMed ID: 17082899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective assessment of influenza vaccine effectiveness among the non-institutionalized elderly population in Japan.
    Ozasa K; Kawahito Y; Doi T; Watanabe Y; Washio M; Mori M; Kase T; Maeda A; Hirota Y
    Vaccine; 2006 Mar; 24(14):2537-43. PubMed ID: 16417955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care.
    Potter JM; O'Donnel B; Carman WF; Roberts MA; Stott DJ
    Age Ageing; 1999 Mar; 28(2):141-5. PubMed ID: 10350410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals.
    Goronzy JJ; Fulbright JW; Crowson CS; Poland GA; O'Fallon WM; Weyand CM
    J Virol; 2001 Dec; 75(24):12182-7. PubMed ID: 11711609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic of humoral response of elderly to inactivated influenza vaccine.
    Siennicka J
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):389-94. PubMed ID: 9017157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.
    Lina B; Fletcher MA; Valette M; Saliou P; Aymard M
    Biologicals; 2000 Jun; 28(2):95-103. PubMed ID: 10885616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral response to influenza hemagglutinin: oligoclonal spectrotype and failure of thymopentin as immunoadjuvant.
    Biselli R; Fagiolo U; Nisini R; Paganelli R; D'Offizi G; Ferrara R; Bertollo L; D'Amelio R
    Gerontology; 1995; 41(1):3-10. PubMed ID: 7737532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.